Moreover, considering the role of target receptor HTR2C and efflux transporter P-gp in risperidone pharmacokinetics, we hypothesized that polymorphisms in the HTR2C and ABCB1 genes might impact obesity in children and adolescents treated with risperidone. The gene discussed is ABCB1; the disease is Obesity.